Compile Data Set for Download or QSAR
Report error Found 40 Enz. Inhib. hit(s) with all data for entry = 8373
TargetAndrogen receptor [E709Y](Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245167(US9428460, 23)
Affinity DataIC50: 9nMT: 2°CAssay Description:PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor [E709Y](Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245168(US9428460, 24)
Affinity DataIC50: 14nMT: 2°CAssay Description:PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245170(US9428460, 26)
Affinity DataIC50: 18nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245146(US9428460, 2)
Affinity DataIC50: 20nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor [W742C](Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245167(US9428460, 23)
Affinity DataIC50: 30nMT: 2°CAssay Description:PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245163(US9428460, 19)
Affinity DataIC50: 32nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245174(US9428460, 30)
Affinity DataIC50: 39nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245147(US9428460, 3)
Affinity DataIC50: 45nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245172(US9428460, 28)
Affinity DataIC50: 45nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245167(US9428460, 23)
Affinity DataIC50: 52nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor [E709Y](Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245153(US9428460, 9)
Affinity DataIC50: 56nMT: 2°CAssay Description:PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245173(US9428460, 29)
Affinity DataIC50: 61nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245171(US9428460, 27)
Affinity DataIC50: 67nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245158(US9428460, 14)
Affinity DataIC50: 68nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor [W742C](Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245168(US9428460, 24)
Affinity DataIC50: 72nMT: 2°CAssay Description:PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor [W742C](Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245153(US9428460, 9)
Affinity DataIC50: 72nMT: 2°CAssay Description:PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245168(US9428460, 24)
Affinity DataIC50: 92nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245156(US9428460, 12)
Affinity DataIC50: 93nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245153(US9428460, 9)
Affinity DataIC50: 105nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245169(US9428460, 25)
Affinity DataIC50: 140nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245157(US9428460, 13)
Affinity DataIC50: 170nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor [E709Y](Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245154(US9428460, 10)
Affinity DataIC50: 175nMT: 2°CAssay Description:PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245162(US9428460, 18)
Affinity DataIC50: 190nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245154(US9428460, 10)
Affinity DataIC50: 194nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245148(US9428460, 4)
Affinity DataIC50: 210nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245155(US9428460, 11)
Affinity DataIC50: 210nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor [W742C](Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245154(US9428460, 10)
Affinity DataIC50: 220nMT: 2°CAssay Description:PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245145(US9428460, 1)
Affinity DataIC50: 240nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245159(US9428460, 15)
Affinity DataIC50: 261nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245166(US9428460, 22)
Affinity DataIC50: 330nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245152(US9428460, 8)
Affinity DataIC50: 420nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245149(US9428460, 5)
Affinity DataIC50: 460nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245160(US9428460, 16)
Affinity DataIC50: 463nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245161(US9428460, 17)
Affinity DataIC50: 477nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245151(US9428460, 7)
Affinity DataIC50: 480nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245165(US9428460, 21)
Affinity DataIC50: 630nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245176(US9428460, 32)
Affinity DataIC50: 650nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245164(US9428460, 20)
Affinity DataIC50: 690nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245175(US9428460, 31)
Affinity DataIC50: 720nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAndrogen receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM245150(US9428460, 6)
Affinity DataIC50: 740nMT: 2°CAssay Description:For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Uro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent